Preparation method and application of isatis root polysaccharide nano-drug delivery carrier with ROS (reactive oxygen species) removal effect

Nanodies delivered by isatis polysaccharide and polysulfide polypropylene solves the problems of limited efficacy and toxic side effects of drug in IBD treatment, and achieves efficient ROS removal and mucosal repair, improving the bioavailability and therapeutic activity of the drug.

CN118903447APending Publication Date: 2024-11-08ZHENGZHOU UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410172502.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-02-07
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The current IBD treatment drugs have limited efficacy and are prone to resistance when used for a long time. How to accurately control the release of drugs, improve the efficacy and reduce toxic side effects is a key issue.

Method used

The nanodrug delivery vehicle constructed with isatis polysaccharide and polysulfide propylene is used to efficiently remove excess ROS through redox reactions and responsively release drugs in a high ROS environment, combining the immune regulation and mucosal repair functions of isatis polysaccharide.

Benefits of technology

Effectively remove ROS, repair intestinal mucosal damage, improve drug bioavailability and therapeutic activity, reduce toxic and side effects, and significantly improve the therapeutic effect of inflammatory bowel disease.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a preparation method and application of an isatis root polysaccharide nano-drug delivery carrier with an ROS (reactive oxygen species) removal effect, which can effectively solve the problems of repairing intestinal mucosa injury, efficiently removing excessive ROS (reactive oxygen species) and improving oral bioavailability and therapeutic activity of drugs. 3-mercaptopropionic acid or 4-mercaptobutyric acid and propylene sulfide generate PPS under the strong alkaline condition, then the PPS is added into an oxidized isatis root polysaccharide solution, a reaction is carried out for 24 h at the room temperature under nitrogen protection, dialysis and freeze drying are carried out, and the isatis root polysaccharide drug delivery carrier IPN with the ROS removal effect is obtained. The prepared nano-drug delivery carrier not only can effectively remove ROS, repair intestinal mucosa injury and enhance intestinal immunocompetence, but also can responsively release drugs in a high ROS environment, improve the therapeutic effect of the drugs and reduce toxic and side effects, and is a new strategy for developing drugs for treating inflammatory bowel diseases.
Need to check novelty before this filing date? Find Prior Art

Description

1. Technical Field

[0001] The invention relates to the field of medical technology, and in particular to a preparation method of a Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect and application thereof. 2. Background Technology

[0002] Inflammatory bowel disease (IBD) is a chronic disease characterized by nonspecific inflammation, which mainly affects the rectal and colonic mucosa and submucosa, and is more common in young people. In recent years, the prevalence of IBD has increased significantly worldwide, but its etiology and pathogenesis are still unclear. More seriously, the current commonly used clinical therapeutic drugs, such as aromatic acids, steroids and hormone drugs, have very limited therapeutic effects, and long-term use is prone to drug resistance. Therefore, how to accurately control the release of drugs, improve efficacy, and reduce toxic side effects is the key to the treatment of IBD. Excessive formation of reactive oxygen species (ROS) is the most important feature of inflammation and is closely related to the occurrence and development of IBD. Data show that ROS in the intestinal mucosa of IBD patients is 10-100 times higher than that of the healthy group. Excessive ROS not only destroys the integrity of the intestinal mucosa, but also can induce mitochondrial dysfunction in cells, aggravate endoplasmic reticulum stress, lead to cell apoptosis and activation of pro-inflammatory mechanisms, and then aggravate the disease process. Therefore, clearing endogenous ROS and responsively releasing therapeutic drugs are crucial for the effective treatment of IBD.

[0003] Polysaccharide-based nanomaterials are the most common type of drug delivery carriers. They not only have the characteristics of strong stability, good biocompatibility, and high safety, but also are rich in active functional groups such as hydroxyl and carboxyl groups in their structures, which makes them very easy to carry out functional modification. Radix Isatidis polysaccharides are a type of polysaccharide extracted from the traditional Chinese medicine Radix Isatidis. Some researchers have used Radix Isatidis polysaccharides to construct block copolymer nanospheres and used them for immune-related treatments. In addition, Radix Isatidis polysaccharides can also restore intestinal mucosal damage caused by lipopolysaccharide and improve the immune function of intestinal tissues, which suggests that Radix Isatidis polysaccharides may play an active role in the treatment of inflammatory bowel disease as an active drug delivery carrier. Polypropylene sulfide (PPS) is a sulfur-containing copolymer that can undergo redox reactions with ROS. On the one hand, ROS are efficiently removed through the reaction; on the other hand, after the sulfur in the structure is oxidized to sulfone and sulfoxide, PPS changes from hydrophobic to hydrophilic, which is conducive to the release of loaded drugs. Therefore, an amphiphilic conjugate with ROS scavenging effect was constructed by PPS and Radix Isatidis polysaccharide, in which Radix Isatidis polysaccharide can relieve IBD symptoms through immune regulation and mucosal repair, and PPS exerts IBD therapeutic activity as a ROS scavenging and drug controlled release unit. This nanodrug delivery carrier prepared using the pathological characteristics of inflammatory bowel disease is safe and highly effective, but has not been publicly reported yet. III. Summary of the invention

[0004] In view of the above situation, in order to solve the defects of the prior art, the purpose of the present invention is to provide a preparation method and application of Isatis polysaccharide nano drug delivery carrier with ROS scavenging effect, which can effectively solve the problems of intestinal mucosal damage repair, efficiently remove excess ROS, and improve the oral bioavailability and therapeutic activity of drugs.

[0005] The technical solution solved by the present invention is that the preparation method of the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect is as follows: 3-mercaptopropionic acid or 4-mercaptobutyric acid and propylene sulfide generate polypropylene sulfide PPS under strong alkaline conditions, then add it to an oxidized Radix Isatidis polysaccharide solution, react at room temperature for 24 hours under nitrogen protection, and obtain the Radix Isatidis polysaccharide drug delivery carrier IPN with ROS scavenging effect through dialysis and freeze-drying.

[0006] The preparation method specifically comprises the following steps:

[0007] 1) Activation of Radix Isatidis Polysaccharides

[0008] The Radix Isatidis polysaccharide RIPS is dissolved in an aqueous solution containing NaBr (sodium bromide) and TEMPO (2,2,6,6-tetramethylpiperidinium-N-oxyl free radical), and the pH of the solution is adjusted to be alkaline by adding NaOH solution. At room temperature, NaClO is added to carry out oxidation to different degrees. After reacting for 4 hours, ethanol is added to terminate the reaction. The solution is adjusted to acidity with HCl solution, dialyzed with a dialysis bag for 24 hours, and freeze-dried to obtain oxidized Radix Isatidis polysaccharide ORIPS.

[0009] Or 100 mg of Radix Isatidis polysaccharide RIPS was dissolved in 20 ml of ultrapure water, and an equal amount of potassium periodate was added under stirring, and the mixture was reacted at room temperature in the dark under argon protection for 24 hours, and then 100 μl of ethylenediamine diphosphate buffer solution was slowly added dropwise, and the mixture was reacted in the dark under argon protection for 24 hours, and the activated Radix Isatidis polysaccharide was obtained after dialysis;

[0010] Or dissolve 50 mg of Radix Isatidis polysaccharide in 25 ml of dimethyl sulfoxide, add 20 mg of maleic anhydride and 5 mg of dimethylaminopyridine, stir at 50°C for 24 h, dialyze the reaction solution in ultrapure water for 1 day, and freeze-dry to obtain activated Radix Isatidis polysaccharide;

[0011] 2) Synthesis of PPS

[0012] 3-mercaptopropionic acid or 4-mercaptobutyric acid is added to anhydrous tetrahydrofuran under stirring, and 1,8-diazabicyclo[5.4.0]-7-undecene is added to the above reaction system under ice bath conditions, and reacted for 30 minutes under a nitrogen atmosphere; then, propylene sulfide is added, and the reaction mixture is stirred at 55°C-70°C overnight, and 5 ml of H2O is added to quench the reaction, and cold methanol precipitation is performed for purification, and reduced pressure evaporation is performed to obtain oily PPS;

[0013] 3) Preparation of Nano-drug Delivery Carriers

[0014] The PPS prepared in step 2) is dissolved in dichloromethane, activated with NHS (N-hydroxysuccinimide) and EDCI (1-ethyl-3 (3-dimethylpropylamine) carbodiimide) for 30 minutes, and then ethylenediamine is added dropwise to the mixture, stirred at room temperature overnight, and then 20 ml of dichloromethane is added to dilute the reaction mixture, washed with H2O and saturated brine in sequence, dried with MgSO4, filtered, and concentrated under reduced pressure to obtain PPS-NH2; the oxidized Radix Isatidis polysaccharide ORIPS prepared in step 1) is dissolved in 10 ml of H2O, and NHS and EDCI are added and stirred at room temperature for 30 minutes to obtain a mixed solution containing polysaccharides; the solution containing PPS-NH2 is dissolved in tetrahydrofuran, and then added dropwise to the mixed solution containing polysaccharides, reacted at room temperature for 24 hours under nitrogen protection, and then dialyzed in water / methanol 1:1 and water for 1 day, respectively, and freeze-dried to remove the solvent to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect;

[0015] Alternatively, the activated Radix Isatidis polysaccharide was mixed with 0.5 times the mass ratio of PPS, and reacted at room temperature for 24 hours under argon protection. After the reaction, the crude product was placed in a dialysis bag (MWCO = 3500Da), and dialyzed in water / methanol 1:1 and water for 1 day respectively, and freeze-dried to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect;

[0016] Or 100 mg PPS was dissolved in 30 ml dichloromethane, 35 mg N, N'-carbonyldiimidazole and 100 μl ethylenediamine were added under stirring, and the mixture was reacted vigorously at room temperature for 4 h under nitrogen protection. Then 250 mg activated Radix Isatidis polysaccharide was added to the solution, and the mixture was reacted at room temperature for 24 h under nitrogen protection. After the reaction, the mixture was dialyzed and freeze-dried to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect.

[0017] The application of the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect in the preparation of drugs for treating inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

[0018] The application of the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect in the preparation of an oral preparation for treating inflammatory bowel disease.

[0019] The preparation process of the invention is simple, the raw material source is abundant, the price is low, and it is suitable for large-scale production. The prepared nano drug delivery carrier can not only effectively remove ROS, repair intestinal mucosal damage, and enhance intestinal immune activity, but also can responsively release drugs in a high ROS environment, thereby improving drug treatment effects and reducing toxic side effects. It is a new strategy for the development of drugs for the treatment of inflammatory bowel disease and has significant economic and social benefits. 4. Specific implementation methods

[0020] The specific implementation modes of the present invention are further described in detail below in conjunction with the embodiments.

[0021] Example 1

[0022] In a specific implementation of the present invention, a method for preparing a Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect comprises the following steps:

[0023] 1) Activation of Radix Isatidis Polysaccharides

[0024] 1 g of Radix Isatidis polysaccharide RIPS was dissolved in 200 ml of an aqueous solution containing 320 mg of NaBr and 32 mg of TEMPO, and a 20% NaOH solution was added to adjust the solution pH to 10.75. Under stirring at room temperature, 5 ml of NaClO was added, and after reacting at room temperature for 4 hours, 2 ml of ethanol solution was added to terminate the reaction. Subsequently, the pH was adjusted to 5 with 6 M HCl, and the solution was dialyzed with ultrapure water for 24 hours. After freeze-drying, the activated Radix Isatidis polysaccharide ORIPS was obtained.

[0025] 2) Synthesis of PPS

[0026] 100 μl (1.15 mmol) of 3-mercaptopropionic acid was added to 30 ml of anhydrous tetrahydrofuran under stirring, and 524 μl (3.45 mmol) of 1,8-diazabicyclo[5.4.0]-7-undecene was added under ice bath conditions, and the mixture was stirred for 30 min under nitrogen atmosphere; then, 1.9 ml (21.15 mmol) of propylene sulfide was added dropwise, and the reaction mixture was stirred at 55°C overnight, 5 ml of H2O was added to quench the reaction, and the mixture was purified by cold methanol precipitation and evaporated under reduced pressure to obtain PPS;

[0027] 3) Preparation of Nano-drug Delivery Carriers

[0028] 150 mg PPS was dissolved in 20 ml dichloromethane, and 25 mg NHS and 50 mg EDCI were added to the solution under stirring. After activation at room temperature for 30 min, 150 μl ethylenediamine was added dropwise to the system and reacted at room temperature for 24 h to obtain PPS-NH2. The above solution was added to the activated 300 mg Radix Isatidis polysaccharide solution and reacted at room temperature for 24 h under nitrogen protection. After the reaction, the crude product was placed in a dialysis bag (MWCO = 3500 Da), dialyzed in water / methanol 1:1 and water for 1 day, and lyophilized to remove the solvent to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect.

[0029] Example 2

[0030] In a specific implementation of the present invention, a method for preparing a Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect comprises the following steps:

[0031] 1) Activation of Radix Isatidis Polysaccharides

[0032] 100 mg of Radix Isatidis polysaccharide RIPS was dissolved in 20 ml of ultrapure water, and an equal amount of potassium periodate was added under stirring, and the mixture was reacted at room temperature in the dark under argon protection for 24 hours, and then 100 μl of ethylenediamine diphosphate buffer solution was slowly added dropwise, and the mixture was reacted in the dark under argon protection for 24 hours. After dialysis, the activated Radix Isatidis polysaccharide was obtained;

[0033] 2) Synthesis of PPS

[0034] 1 mmol of 3-mercaptopropionic acid was added to 30 ml of anhydrous tetrahydrofuran under stirring, and 4 mmol of 1,8-diazabicyclo[5.4.0]-7-undecene was added under ice bath conditions. The mixture was stirred for 30 min under argon protection. Then, 20 mmol of propylene sulfide was added dropwise. The reaction mixture was stirred overnight under ice bath conditions. Ultrapure water was added to quench the reaction. The salt precipitate was removed by filtration, and PPS was obtained by vacuum distillation and ether precipitation.

[0035] 3) Preparation of Nano-drug Delivery Carriers

[0036] The activated Radix Isatidis polysaccharide was mixed with 0.5 times the mass ratio of PPS, and reacted at room temperature for 24 hours under argon protection. After the reaction, the crude product was placed in a dialysis bag (MWCO = 3500Da), and dialyzed in water / methanol 1:1 and water for 1 day each. After freeze-drying, the Radix Isatidis polysaccharide nanodrug delivery carrier IPN with ROS scavenging effect was obtained.

[0037] Example 3

[0038] In a specific implementation of the present invention, a method for preparing a Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect comprises the following steps:

[0039] 1) Activation of Radix Isatidis Polysaccharides

[0040] 50 mg of Radix Isatidis polysaccharide was dissolved in 25 ml of dimethyl sulfoxide, 20 mg of maleic anhydride and 5 mg of dimethylaminopyridine were added, and the mixture was stirred at 50°C for 24 h. The reaction solution was dialyzed in ultrapure water for 1 day, and activated Radix Isatidis polysaccharide was obtained after freeze-drying.

[0041] 2) Synthesis of PPS

[0042] 1.5 mmol 4-mercaptobutyric acid was added to 40 ml anhydrous tetrahydrofuran under stirring, and 4.5 mmol 1,8-diazabicyclo[5.4.0]-7-undecene was added under ice bath condition, and stirred for 30 min under nitrogen atmosphere; then, 25 mmol propylene sulfide was added dropwise, and the reaction mixture was stirred at 55°C overnight, and 5 ml H2O was added to quench the reaction, and PPS was obtained by methanol precipitation and freeze drying;

[0043] 3) Preparation of Nano-drug Delivery Carriers

[0044] 100 mg PPS was dissolved in 30 ml dichloromethane, 35 mg N, N'-carbonyldiimidazole and 100 μl ethylenediamine were added under stirring, and the mixture was reacted vigorously at room temperature for 4 h under nitrogen protection. Then 250 mg activated Radix Isatidis polysaccharide was added to the solution and reacted at room temperature for 24 h under nitrogen protection. After the reaction, the mixture was dialyzed and freeze-dried to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect.

[0045] The Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect prepared by the method described in Examples 1-3 is effectively used in the preparation of therapeutic drugs for inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, as well as in the preparation of oral preparations of therapeutic drugs for inflammatory diseases.

[0046] The nano drug delivery carrier prepared by the present invention has good biocompatibility, can not only effectively remove overexpressed ROS, repair intestinal mucosal damage, and improve the body's immune function, but also can load drugs and deliver them to the site of intestinal inflammation, thereby realizing the application in the delivery of drugs for the treatment of inflammatory bowel disease. After repeated experiments, satisfactory technical effects have been achieved. The relevant experimental data are as follows:

[0047] 1. Drug loading experiment

[0048] Under stirring conditions, the DMF solution containing andrographolide AD was added dropwise to the IPN polymer carrier solution according to different mass ratios, and the stirring was continued at room temperature for 2h. The drug-loaded nanoparticles IPN@AD were obtained by dialysis and freeze-drying. The drug loading and encapsulation efficiency of andrographolide were determined by HPLC. The results showed that with the continuous increase of the content of IPN, its loading capacity on AD gradually increased. When the mass ratio of IPN to AD increased to 2.5:1, the drug loading and encapsulation efficiency reached (15.62±0.15)% and (46.83±1.91)%, respectively. The particle size potential results showed that the particle size of the unloaded IPN was (230.9±3.2)nm and the potential was (-13.9±1.9)mv. After drug loading, the particle size of IPN@AD was (178.5±1.7)nm and the potential was (-3.5±1.3)mv.

[0049] 2. ROS Scavenging Efficiency Experiment

[0050] IPN@AD solutions of different concentrations were added to 10mM H2O2 solution and incubated at 37°C for 24h. The residual H2O2 was detected using a hydrogen peroxide kit and the H2O2 clearance rate was calculated. The results showed that the ROS scavenging activity increased with the increase of IPN@AD concentration. When the IPN@AD concentration reached 1000μg / ml, the H2O2 clearance rate was (45.07±0.07)%.

[0051] 3. In vitro drug release

[0052] In simulated artificial intestinal fluid (pH 7.4), the drug release of the IPN@AD drug delivery system was 41% in 24 hours. When 10mM H2O2 was added to the artificial intestinal fluid to simulate the inflammatory colon environment, the drug release increased to 82%. The experimental results show that the IPN@AD drug delivery system has ROS-responsive drug release function.

[0053] IV. Cytotoxicity Experiment

[0054] The cytotoxicity of the nano drug carrier IPN and the nano drug delivery system IPN@AD was investigated using macrophage Raw264.7 cells. The experimental results showed that even when the concentration of IPN and IPN@AD was as high as 250μg / ml, the survival rate of the treated macrophages was still higher than 90%, indicating that the constructed drug delivery carrier has good biocompatibility.

[0055] 5. In vivo distribution experiment

[0056] The nanocarrier IPN was labeled with IR-783 (the doses of IR-783 and IPN were 0.4 mg / kg and 1 mg / kg, respectively) and orally fed to mice with acute ulcerative colitis. The mice were killed 48 hours later and their main organs were dissected. The results showed that the strongest fluorescence was found in the colon of the mice, while other tissues (heart, liver, spleen, lung, and kidney) had no obvious fluorescence, indicating that IR-783 / IPN can accurately target the colon.

[0057] VI. In vivo pharmacodynamic evaluation

[0058] After 1 week of adaptation, SPF 6-8 week old male C57BL / 6J mice were randomly divided into 6 groups, namely normal control group NC, colitis model group DSS, andrographolide group AD, nanocarrier group IPN and nanodrug carrier group IPN@AD. The NC group was allowed to drink sterile water freely, and the other groups were allowed to drink 3% DSS freely. The NC group and the DSS group were given an equal volume of sterile saline by gavage, and the other groups were given oral administration, with the dosages of andrographolide 100mg / kg and IPN 540mg / kg, respectively. The drugs were administered once a day for 15 consecutive days. The therapeutic effect was evaluated by four indicators, including disease activity index (DAI), mouse colon length, TNF-α and IL-6 content.

[0059] The experimental results showed that compared with the NC group, the other four groups of mice fed with DSS all showed varying degrees of weight loss, diarrhea, and bloody stools. Compared with the DSS group, the DAI index of mice in each drug-treated group was significantly reduced, and the IPN@AD group was the lowest (a 65% decrease compared to the DSS group). Compared with the colon length of the DSS group, the colon length of the IPN and IPN@AD groups increased by 29% and 55%, respectively. In addition, compared with the expression levels of inflammatory factors TNF-α and IL-6 in the DSS group, the other groups all decreased to varying degrees. Compared with the free drug AD group, mice in the IPN@AD group showed significant improvements in the DAI index, colon length, and expression of inflammatory factors, which fully demonstrated that the IPN carrier can enhance the therapeutic activity of drug AD and significantly improve colitis in mice.

[0060] In the above experiments, the drug andrographolide, cell line Raw264.7 macrophages, and experimental animal SPF-grade BALB / c mice used in the present invention are not intended to limit the scope of the present invention, but are used as examples to illustrate the beneficial technical effects of the present invention.

[0061] VII. Conclusion

[0062] Experiments show that the present invention has the following outstanding advantages over the prior art:

[0063] (1) Polypropylene sulfide was covalently grafted onto the backbone of Radix Isatidis polysaccharide to construct an amphiphilic nano drug delivery carrier with ROS scavenging effect;

[0064] (2) The Radix Isatidis polysaccharide unit in the nanocarrier can regulate the intestinal immune microenvironment, repair intestinal mucosal damage, and relieve IBD symptoms. The polypropylene sulfide unit acts as a ROS scavenger, effectively reducing the intestinal ROS content and alleviating intestinal inflammation.

[0065] (3) ROS-responsive drug release can achieve targeted release of drugs at sites of intestinal inflammation, which helps to increase effective drug concentrations, prolong drug treatment time, and reduce toxic side effects.

[0066] (4) The raw materials used in the present invention are abundant in source, the production process is simple, the cost is controllable, and it is suitable for industrial production. It is a major innovation in the treatment of inflammatory bowel disease and has significant economic and social benefits.

[0067] It should be pointed out that the above is only a preferred embodiment of the present invention and does not limit the present invention in any form. Any technician familiar with the profession can make changes or modify the technical contents disclosed above into equivalent embodiments with equivalent changes without departing from the scope of the technical solution of the present invention, which all fall within the protection scope of the present invention.

Claims

1. A method for preparing a Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect, characterized in that: 3-Mercaptopropionic acid or 4-mercaptobutyric acid and propylene sulfide are used to generate polypropylene sulfide (PPS) under strong alkaline conditions, which is then added to an oxidized Radix Isatidis polysaccharide solution and reacted at room temperature for 24 hours under nitrogen protection. After dialysis and freeze-drying, an Isatis polysaccharide drug delivery carrier IPN with ROS scavenging effect is obtained.

2. The method for preparing the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect according to claim 1, characterized in that: The following steps are involved: 1) Activation of Radix Isatidis Polysaccharides Dissolve Radix Isatidis polysaccharide RIPS in an aqueous solution containing NaBr and TEMPO, add NaOH solution to adjust the pH of the solution to be alkaline, add NaClO at room temperature to carry out oxidation to different degrees, react for 4 hours, and then add ethanol to terminate the reaction; adjust the solution to acidity with HCl solution, dialyze with a dialysis bag for 24 hours, and freeze-dry to obtain activated Radix Isatidis polysaccharide ORIPS; Or 100 mg of Radix Isatidis polysaccharide RIPS was dissolved in 20 ml of ultrapure water, and an equal amount of potassium periodate was added under stirring, and the mixture was reacted at room temperature in the dark under argon protection for 24 hours, and then 100 μl of ethylenediamine diphosphate buffer solution was slowly added dropwise, and the mixture was reacted in the dark under argon protection for 24 hours, and the activated Radix Isatidis polysaccharide was obtained after dialysis; Or dissolve 50 mg of Radix Isatidis polysaccharide in 25 ml of dimethyl sulfoxide, add 20 mg of maleic anhydride and 5 mg of dimethylaminopyridine, stir at 50°C for 24 h, dialyze the reaction solution in ultrapure water for 1 day, and freeze-dry to obtain activated Radix Isatidis polysaccharide; 2) Synthesis of PPS 3-mercaptopropionic acid or 4-mercaptobutyric acid is added to anhydrous tetrahydrofuran under stirring, and 1,8-diazabicyclo[5.4.0]-7-undecene is added to the above reaction system under ice bath conditions, and reacted for 30 minutes under a nitrogen atmosphere; then, propylene sulfide is added, and the reaction mixture is stirred at 55°C-70°C overnight, and 5 ml of H2O is added to quench the reaction, and cold methanol precipitation is performed for purification, and reduced pressure evaporation is performed to obtain oily PPS; 3) Preparation of nano drug delivery carriers The PPS prepared in step 2) was dissolved in dichloromethane, activated with NHS and EDCI for 30 minutes, and then ethylenediamine was added dropwise to the mixture, stirred at room temperature overnight, and then 20 ml of dichloromethane was added to dilute the reaction mixture, washed with H2O and saturated brine in turn, dried with MgSO4, filtered, and concentrated under reduced pressure to obtain PPS-NH2. The activated Radix Isatidis polysaccharide ORIPS prepared in step 1) was dissolved in 10 ml of H2O, and NHS and EDCI were added and stirred at room temperature for 30 minutes to obtain a mixed solution containing polysaccharides; the solution containing PPS-NH2 was dissolved in tetrahydrofuran, and then added dropwise to the mixed solution containing polysaccharides, reacted at room temperature for 24 hours under nitrogen protection, and then dialyzed in water / methanol 1:1 and water for 1 day, respectively, and freeze-dried to remove the solvent to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect; Alternatively, the activated Radix Isatidis polysaccharide was mixed with 0.5 times the mass ratio of PPS, and reacted at room temperature for 24 hours under argon protection. After the reaction, the crude product was placed in a dialysis bag, and dialyzed in water / methanol 1:1 and water for 1 day respectively, and freeze-dried to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect; Or 100 mg PPS was dissolved in 30 ml dichloromethane, 35 mg N, N'-carbonyldiimidazole and 100 μl ethylenediamine were added under stirring, and the mixture was reacted vigorously at room temperature for 4 h under nitrogen protection. Then 250 mg activated Radix Isatidis polysaccharide was added to the solution, and the mixture was reacted at room temperature for 24 h under nitrogen protection. After the reaction, the mixture was dialyzed and freeze-dried to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect.

3. The method for preparing the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect according to claim 1, characterized in that: The following steps are involved: 1) Activation of Radix Isatidis Polysaccharides 1 g of Radix Isatidis polysaccharide RIPS was dissolved in 200 ml of an aqueous solution containing 320 mg of NaBr and 32 mg of TEMPO, and a 20% NaOH solution was added to adjust the solution pH to 10.

75. Under stirring at room temperature, 5 ml of NaClO was added, and after reacting at room temperature for 4 h, 2 ml of ethanol solution was added to terminate the reaction. Subsequently, the pH was adjusted to 5 with 6 M HCl, and the solution was dialyzed with ultrapure water for 24 h. After freeze-drying, the activated Radix Isatidis polysaccharide ORIPS was obtained. 2) Synthesis of PPS Under stirring, add 100 μl of 1.15 mmol 3-mercaptopropionic acid to 30 ml of anhydrous tetrahydrofuran, add 524 μl of 3.45 mmol 1,8-diazabicyclo[5.4.0]-7-undecene under ice bath conditions, and stir for 30 min under nitrogen atmosphere; then, add 1.9 ml of 21.15 mmol propylene sulfide dropwise, stir the reaction mixture at 55°C overnight, add 5 ml of H2O to quench the reaction, precipitate with cold methanol for purification, and evaporate under reduced pressure to obtain PPS; 3) Preparation of nano drug delivery carriers 150 mg PPS was dissolved in 20 ml dichloromethane, and 25 mg NHS and 50 mg EDCI were added to the solution under stirring. After activation at room temperature for 30 min, 150 μl ethylenediamine was added dropwise to the system and reacted at room temperature for 24 h to obtain PPS-NH2. The above solution was added to the activated 300 mg Radix Isatidis polysaccharide solution and reacted at room temperature for 24 h under nitrogen protection. After the reaction, the crude product was placed in a dialysis bag and dialyzed in water / methanol 1:1 and water for 1 day, and lyophilized to remove the solvent to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect.

4. The method for preparing the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect according to claim 1, characterized in that: The following steps are involved: 1) Activation of Radix Isatidis Polysaccharides 100 mg of Radix Isatidis polysaccharide RIPS was dissolved in 20 ml of ultrapure water, and an equal amount of potassium periodate was added under stirring, and the mixture was reacted at room temperature in the dark under argon protection for 24 hours, and then 100 μl of ethylenediamine diphosphate buffer solution was slowly added dropwise, and the mixture was reacted in the dark under argon protection for 24 hours. After dialysis, the activated Radix Isatidis polysaccharide was obtained; 2) Synthesis of PPS 1 mmol of 3-mercaptopropionic acid was added to 30 ml of anhydrous tetrahydrofuran under stirring, and 4 mmol of 1,8-diazabicyclo[5.4.0]-7-undecene was added under ice bath conditions, and the mixture was stirred for 30 min under argon protection. Then, 20 mmol of propylene sulfide was added dropwise, and the reaction mixture was stirred overnight under ice bath conditions. Ultrapure water was added to quench the reaction, and the salt precipitate was removed by filtration. PPS was obtained by vacuum distillation and ether precipitation. 3) Preparation of nano drug delivery carriers The activated Radix Isatidis polysaccharide was mixed with 0.5 times the mass ratio of PPS, and reacted at room temperature for 24 hours under argon protection. After the reaction, the crude product was placed in a dialysis bag and dialyzed in water / methanol 1:1 and water for 1 day respectively. After freeze-drying, the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect was obtained.

5. The method for preparing the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect according to claim 1, characterized in that: The following steps are involved: 1) Activation of Radix Isatidis Polysaccharides 50 mg of Radix Isatidis polysaccharide was dissolved in 25 ml of dimethyl sulfoxide, 20 mg of maleic anhydride and 5 mg of dimethylaminopyridine were added, and the mixture was stirred at 50°C for 24 h. The reaction solution was dialyzed in ultrapure water for 1 day, and activated Radix Isatidis polysaccharide was obtained after freeze-drying. 2) Synthesis of PPS 1.5 mmol 4-mercaptobutyric acid was added to 40 ml anhydrous tetrahydrofuran under stirring, and 4.5 mmol 1,8-diazabicyclo[5.4.0]-7-undecene was added under ice bath conditions, and the mixture was stirred for 30 min under nitrogen atmosphere; then, 25 mmol propylene sulfide was added dropwise, and the reaction mixture was stirred at 55°C overnight, and 5 ml H2O was added to quench the reaction, and PPS was obtained by methanol precipitation and freeze drying; 3) Preparation of nano drug delivery carriers 100 mg PPS was dissolved in 30 ml dichloromethane, 35 mg N, N'-carbonyldiimidazole and 100 μl ethylenediamine were added under stirring, and the mixture was reacted vigorously at room temperature for 4 h under nitrogen protection. Then 250 mg activated Radix Isatidis polysaccharide was added to the solution and reacted at room temperature for 24 h under nitrogen protection. After the reaction, the mixture was dialyzed and freeze-dried to obtain the Radix Isatidis polysaccharide nano drug delivery carrier IPN with ROS scavenging effect.

6. Use of the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect prepared by the method of any one of claims 1 to 5 in the preparation of drugs for treating inflammatory bowel disease.

7. Use of the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect prepared by the method of any one of claims 1 to 5 in the preparation of an oral preparation for treating inflammatory bowel disease.

8. Use of the Radix Isatidis polysaccharide nano drug delivery carrier with ROS scavenging effect prepared by the method of any one of claims 1 to 5 in the preparation of drugs for treating Crohn's disease and ulcerative colitis.

Citation Information

Cited By

  • Hydrogel for treating ischemic brain injury and preparation method thereof

    CN119424318A